Wegovy

showdown clash versus vs crash lightning fight dispute
Pharma

The Oral GLP-1 Tracker: Scripts bounce back from holiday lull

Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
New York Stock Exchange building

Novo is open to a direct listing on the New York Stock Exchange

Sep 23, 2026 11:28am
Novo Mike Doustdar 2

Novo struggles to appease restless investors with new strategy

Sep 21, 2026 10:50am
Mike Doustdar

Novo CEO talks embracing change and staying bullish amid rebrand

Sep 17, 2026 8:45am
Doustdar

No more Nordisk as Novo goes it alone amid rebranding push

Sep 14, 2026 6:54am
Novo Nordisk

Wegovy helps free 40% of kids from obesity in phase 3 trial

Sep 8, 2026 11:07am